Status:
COMPLETED
AZD9056 Relative Bioavailability Study
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The aims of this study are to compare the blood levels achieved with a new formulation of AZD9056 to an existing formulation of AZD9056 used in previous studies.
Eligibility Criteria
Inclusion
- Provision of informed consent prior to any study-specific procedures
- Healthy Volunteers, Females should not be of childbearing potential
- BMI between 18 and 30 kg/m2
Exclusion
- Clinically significant ECG abnormality suggestive of underlying cardiovascular disease
- A history or presence of GI, hepatic or renal disease or other condition known to interfere with the absorption, distribution, metabolism and excretion of drugs
- Known or suspected drug or alcohol abuse or positive DOA test
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00908934
Start Date
May 1 2009
End Date
July 1 2009
Last Update
July 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Manchester, United Kingdom